Skip to main content
logo
Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3800
+0.0010 (0.26%)
At close: Oct 2, 2026

EPA:ALOPM Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
77133012
Market Cap Growth
-25.62%-42.44%-56.74%155.14%-
Enterprise Value
11121123-
Last Close Price
0.380.410.711.811.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
1.261.36---
Forward PE
-0.21---
PS Ratio
3.984.127.9317.241.42
PB Ratio
1.241.29-30.218.131.00
P/TBV Ratio
1.521.57-11.791.07

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
6.346.377.0113.18-
EV/EBITDA Ratio
1.901.91---
EV/EBIT Ratio
2.012.02---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
1.101.10-17.652.390.22
Debt / EBITDA Ratio
1.061.06---
Net Debt / Equity Ratio
0.740.74-5.37-0.41-0.91
Net Debt / EBITDA Ratio
0.710.71-0.310.167.45
Asset Turnover
0.140.140.120.10-
Quick Ratio
0.380.382.653.454.10
Current Ratio
1.861.862.803.534.14
Return on Equity (ROE)
203.90%203.90%-442.13%-104.58%-
Return on Assets (ROA)
27.76%27.76%-35.69%-35.51%-
Return on Invested Capital (ROIC)
56.32%64.11%-159.27%-623.13%-159.34%
Return on Capital Employed (ROCE)
72.60%72.60%-102.40%-79.20%-11.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
75.94%73.39%-55.58%-26.98%-1.97%
Buyback Yield / Dilution
-1.34%-1.34%-9.16%0.48%-